sábado, 7 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Tripadvisor upgraded by Bank of America amid rising activist engagement

View original at finance.yahoo.com
Tripadvisor upgraded by Bank of America amid rising activist engagement Tripadvisor upgraded by Bank of America amid rising activist engagement Proactive uses images sourced from Shutterstock Bank of America has upgraded its rating on Tripadvisor Inc (NASDAQ:TRIP) to ‘Buy’ from ‘Neutral,’ citing accelerating activist i…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Viator is valued between $1.3 billion and $2.5 billion

    60% confidence

  • Tripadvisor's hotel meta-search business continues to face structural headwinds

    60% confidence

  • We see a clearer catalyst path for value realization driven by accelerating activist engagement and rising strategic optionality across the portfolio

    60% confidence

  • TheFork is estimated between $372 million and $1.1 billion

    60% confidence

  • Bank of America believes the addition of four new directors improves the likelihood of asset-level actions

    60% confidence

  • Tripadvisor's experiences marketplace Viator and European restaurant reservation platform TheFork could be worth more than $2.5 billion combined, roughly double the company's current enterprise value

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
Tripadvisor upgraded by Bank of America amid rising activist engagement — Source | Via News | es.VIA.NEWS